CANCLINI, LAURA
CANCLINI, LAURA
Mostra
records
Risultati 1 - 3 di 3 (tempo di esecuzione: 0.0 secondi).
PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 PREFERENTIALLY ASSOCIATES WITH A SPECIFIC LDL SUBFRACTION: A DETAILED CHARACTERIZATION AND STUDY OF THE EFFECTS OF ANTI-PCSK9 MABS TREATMENT
2022 L. Canclini
The association of proprotein convertase subtilisin/kexin type 9 to plasma low-density lipoproteins: An evaluation of different methods
2021 L. Canclini, A.M. Malvandi, P. Uboldi, N. Jabnati, L. Grigore, A. Zambon, A. Baragetti, A.L. Catapano
Progress and prospects of biological approaches targeting PCSK9 for cholesterol-lowering, from molecular mechanism to clinical efficacy
2020 A.M. Malvandi, L. Canclini, A. Alliaj, P. Magni, A. Zambon, A.L. Catapano